ANUCIA JOSEPH: Open Payments
NPI 1174809941 · MISSION, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 6 payments from 5 companies in 2025. Trend: 2023 $3,723 · 2024 $3,425 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $229 |
| Neurocrine BioSciences, Inc. | 1 | $138 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Vanda Pharmaceuticals Inc. | 1 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $52 |
Products named: COBENFY, INGREZZA, ABILIFY MAINTENA, FANAPT.
Industry payments across KS — which companies pay providers there.
